The promising figures made Bayer back its full-year outlook
The German pharmaceutical company, Bayer, reported quarterly
figures that came ahead of the estimates.
The first quarter of the year revealed an EPS of €2.59 on
revenues of €12.33 billion. Analysts were looking for an EPS of €2.47 and
revenue of €12 billion.
For 2021, Bayer
reiterated its sales expectations of €42 billion - €43 billion.
After the report, Bayer stock price added 4.88%.
Year-to-date, its shares gained 16%.
Source: marketwatch.com
This information prepared by ClickTrades.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.
This information is prepared for general circulation. It does not have regard to the specific investment objectives, financial situation or the particular needs of any recipient.
You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.
This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of ClickTrades.com.
Previous Article
Coty’s Q3 figures came in line with expectations
Next Article
Mixed bag of results for Airbnb
